Iovance Biotherapeutics
Rana Fiaz, M.D. has a background in clinical research and management within the healthcare industry. With experience in various roles at prestigious institutions such as Stanford Cancer Center and UCLA Stroke Center, they have developed a strong foundation in clinical science. Currently serving as Senior Medical Director at Iovance Biotherapeutics, Inc., Rana's expertise and education from Rajiv Gandhi University of Health Sciences have positioned them as a valuable asset in the field of medicine.
This person is not in any teams
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.